Loading ...

Joy Laurienzo

NIAID

Assessment Group

JLaurienzo@niaid.nih.gov

Work:

301-451-4415

Mobile:

Address:

NIAID

Committees:

,

Studies:

ITN019AD

-

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

ITN025AD

-

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children

ITN031AD

-

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN043AD

-

Long-Term Effects of Sublingual Grass Therapy

ITN048AD

-

ITN049AD

-

Persistence of Oral Tolerance to Peanut

ITN050AD

-

Peanut Oral Immunotherapy in Children

ITN052AD

-

Peanut Protein Quantification Study for LEAP

ITN053AD

-

Peanut protein quantification study for LEAP-ON

ITN057AD

-

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

ITN060AD

-

Peanut Allergy Sensitisation Study

ITN070AD

-

ITN072AD

-

GLA-AF plus antigen-specific immunotherapy in individuals with seasonal allergic rhinitis

ITN079AD

-

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

Bio:

Admin Links

Shortcuts

ITN Documents

Links